GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.

Por Lumley, P., White, B. P., Humphrey, P. P.
Publicado em 1989

Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.

Por Watts, I. S., Wharton, K. A., White, B. P., Lumley, P.
Publicado em 1991

Resistance and susceptibility to the induction of rat adjuvant disease. Diverging susceptibility and severity achieved by selective breeding.

Por MacKenzie, A. R., Sibley, P. R., White, B. P.
Publicado em 1979

Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the disease.

Por Mackenzie, A R, Pick, C R, Sibley, P R, White, B P
Publicado em 1978